PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Handel & varor |
| Industri | Sällanköpsvaror |
Company announcement no. 13-2025
August 29, 2025
Audientes A/S ("Audientes" or the "Company"), CVR 36047631, announces its unaudited financial results for Q2 and Half-year 2025. The Company provides updates on progress in its key markets and on product development.
Operating Highlights for Q2/Half-year 2025
- Orders for second half-year (H2) revenue recognition: Orders totalling DKK 0.8 million received in Q2 from our strategic partner SimplyJITH Holdings, to be delivered and recognised in Q3, providing additional runway through new sales inflows.
- China regulatory progress and market entry: Progressed medical device submission toward NMPA approval of our Ven™ hearing aid, a key step into the regulated Chinese hearing aid market.
- Middle East and North Africa (MENA-region) expansion: Our partner Audivista of Turkey, with whom we entered a collaboration agreement earlier in 2025, is advancing both e-commerce initiatives and public health sector opportunities, including engagement with government stakeholders and local market preparations. Commercial orders of significant size are expected in H2 2025.
- E-commerce in Europe: Our Amazon sales partner RMX Digital has gone live with our Companion advanced hearable product on Amazon UK, with rollout across further European storefronts expected in H2 2025.
- Japan market entry: Launched own e-commerce campaign site in late Q2 for our Japanese Companion advanced hearable, with further ecommerce expansion planned once marketing funding is secured.
Financial highlights for Q2/Half-year 2025
| TDKK | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | 2024 |
| Revenue | 4 | 12 | 84 | 27 | 630 |
| Other operating income | 214 | 214 | 441 | 428 | 1,068 |
| EBITDA | -1,520 | -1,713 | -3,127 | -3,029 | -5,379 |
| Profit/loss for the period | -3,282 | -3,139 | -6,293 | -5,740 | -10,733 |
| Cash and cash equivalents | 7 | 47 | 7 | 47 | 9 |
| Equity | -1,216 | 3,491 | -1,216 | 3,491 | 1,199 |
| Equity ratio (%) | -18.6% | 30.9% | -18.6% | 30.9% | 13.6% |
| Earnings per share (DKK) | -0.01 | -0.02 | -0.01 | -0.04 | -0.05 |
| No. of shares beginning of the period | 488,666,181 | 69,384,318 | 399,411,640 | 59,384,318 | 59,384,318 |
| No. of shares end of period | 678,551,252 | 200,392,676 | 678,551,252 | 200,392,676 | 399,411,640 |
| Average number of shares | 583,608,717 | 134,888,497 | 538,981,446 | 129,888,497 | 229,397,979 |
In April 2024, the nominal value per share was reduced from DKK 0.10 to DKK 0.01. At the same time, the nominal share capital was reduced by DKK 6,244,589, corresponding to 624,458,900 shares, each with a nominal value of DKK 0.01.
- Revenue performance: Revenue from product sales amounted to TDKK 4 in Q2 2025 compared to TDKK 12 in the same quarter last year. For H1 2025, revenue amounted to TDKK 84 versus TDKK 27 in H1 2024.
- EBITDA: Negative EBITDA of TDKK -1,520 in Q2, which was weaker than expected due to delays in sales shifting from Q2 to Q3.
- Convertible loans: Convertible loans were in Q2 2025 lowered with TDKK 1,276 net fully driven by conversion of debt to equity by the lenders. Convertible loans amounts to TDKK 0 at the end of June 2025.
- Negative equity: As of end Q2 2025, equity amounted to negative DKK 1.2 million. While more than 50% of the share capital has been lost due to operating losses, management remains confident in reestablishing equity through future profitability and new financing.
- Financing strategy: The company continues to pursue additional funding to support operations and growth. The targeted corporate bond of up to DKK 15 million (EUR 2 million) on the Bulgarian BEAM market, originally planned for Q2, is now expected to launch in September 2025 following completion of information requirements and project resourcing.
Financial calendar
The Company's financial calendar is updated, as follows:
| Date | Event |
| August 29, 2025 | Q2 / half-year 2025 reporting |
| November 21, 2025 | Q3 2025 reporting |
| February 24, 2026 | Q4 / end of year 2025 reporting |
| April 14, 2026 | Annual Report 2025 |
| May 7, 2026 | Annual General Meeting |
| May 28, 2026 | Q1 2026 reporting |
| August 27, 2026 | Q2/half-year 2026 reporting |
| November 19, 2026 | Q3 2026 reporting |
For further information, please contact:
Steen Thygesen, CEO, Audientes A/S
Phone: +45 77 34 16 80
Email: st@audientes.com
About Audientes A/S
Audientes A/S is a Danish hearing technology company specializing in smart, self-fitting and affordable hearing aids, hearables, and hearing protection solutions. Our mission is to make high-quality hearing technology accessible to everyone - whether for hearing improvement, enhancement, or protection - across consumer, medical, and industrial sectors worldwide.
In addition to our own products, we are developing a licensing business based on our proprietary software and hearing technology platform. This allows third-party brands, OEMs and manufacturers to integrate our proven self-fitting and audio processing capabilities into their own hearing products and solutions, thereby expanding our global reach and revenue potential.
Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in Copenhagen, Denmark, with subsidiaries in Hyderabad, India, and in Tokyo, Japan. Audientes also holds a 40% stake in a joint venture, ZhiYinYou Technology Limited, with Shenzhen Hengtong Partner Co. Ltd. in China.
For more information, please visit our websites www.audientes.com, www.audientes.eu, www.audientes.co.jp, www.audientes.in, or follow us on our social media channels.